======= MAML1 ======= == Gene Information == * **Official Symbol**: MAML1 * **Official Name**: mastermind like transcriptional coactivator 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9794|9794]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92585|Q92585]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MAML1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MAML1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605424|Open OMIM]] == Function Summary == * **Entrez Summary**: This protein is the human homolog of mastermind, a Drosophila protein that plays a role in the Notch signaling pathway involved in cell-fate determination. There is in vitro evidence that the human homolog forms a complex with the intracellular portion of human Notch receptors and can increase expression of a Notch-induced gene. This evidence supports its proposed function as a transcriptional co-activator in the Notch signaling pathway. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Acts as a transcriptional coactivator for NOTCH proteins. Has been shown to amplify NOTCH-induced transcription of HES1. Enhances phosphorylation and proteolytic turnover of the NOTCH intracellular domain in the nucleus through interaction with CDK8. Binds to CREBBP/CBP which promotes nucleosome acetylation at NOTCH enhancers and activates transcription. Induces phosphorylation and localization of CREBBP to nuclear foci. Plays a role in hematopoietic development by regulating NOTCH-mediated lymphoid cell fate decisions. {ECO:0000269|PubMed:11101851, ECO:0000269|PubMed:11390662, ECO:0000269|PubMed:12050117, ECO:0000269|PubMed:15546612, ECO:0000269|PubMed:17317671}. |MamL-1| |cardiac septum cell differentiation| |atrioventricular node cell differentiation| |atrioventricular node cell development| |MAML1-RBP-Jkappa- ICN1 complex| |atrioventricular node development| |cardiac pacemaker cell development| |cardiac pacemaker cell differentiation| |cardiac conduction system development| |positive regulation of transcription of Notch receptor target| |positive regulation of myotube differentiation| |peptide antigen binding| |myoblast differentiation| |positive regulation of Notch signaling pathway| |regulation of myotube differentiation| |positive regulation of striated muscle cell differentiation| |cardiac muscle cell development| |cardiac cell development| |positive regulation of muscle cell differentiation| |cardiac muscle cell differentiation| |regulation of striated muscle cell differentiation| |regulation of Notch signaling pathway| |cardiac septum development| |cardiocyte differentiation| |Notch signaling pathway| |striated muscle cell development| |muscle cell development| |regulation of muscle cell differentiation| |cardiac muscle tissue development| |cardiac chamber development| |transcription initiation from RNA polymerase II promoter| |striated muscle cell differentiation| |DNA-templated transcription, initiation| |muscle cell differentiation| |striated muscle tissue development| |transcription coactivator activity| |muscle tissue development| |nuclear speck| |protein kinase binding| |muscle structure development| |transcription by RNA polymerase II| |heart development| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |intracellular membrane-bounded organelle| |circulatory system development| |positive regulation of cell differentiation| |protein phosphorylation| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |positive regulation of transcription by RNA polymerase II| |phosphorylation| |organic cyclic compound biosynthetic process| |positive regulation of developmental process| |positive regulation of transcription, DNA-templated| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |positive regulation of signal transduction| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |tissue development| |macromolecule biosynthetic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|-1.86| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|-1.79| |[[:results:exp210|LB-100 2μM R05 exp210]]|-1.79| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|-1.78| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|-1.77| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|-1.73| |[[:results:exp517|Quercetin 20μM R08 exp517]]|1.96| ^Gene^Correlation^ |[[:human genes:s:ssbp2|SSBP2]]|0.542| |[[:human genes:i:id3|ID3]]|0.54| |[[:human genes:z:zfx|ZFX]]|0.519| |[[:human genes:t:taf5l|TAF5L]]|0.509| |[[:human genes:i:irf2bp2|IRF2BP2]]|0.507| |[[:human genes:c:ccdc101|CCDC101]]|0.501| |[[:human genes:c:cbfb|CBFB]]|0.498| |[[:human genes:z:znf592|ZNF592]]|0.495| |[[:human genes:m:mef2c|MEF2C]]|0.483| |[[:human genes:r:runx1|RUNX1]]|0.482| |[[:human genes:c:ctdspl2|CTDSPL2]]|0.476| |[[:human genes:t:trim33|TRIM33]]|0.473| |[[:human genes:n:nsd1|NSD1]]|0.471| |[[:human genes:s:sox7|SOX7]]|0.467| |[[:human genes:f:fli1|FLI1]]|0.463| |[[:human genes:l:ldb1|LDB1]]|0.455| |[[:human genes:t:trmt10a|TRMT10A]]|0.454| |[[:human genes:z:zmym2|ZMYM2]]|0.453| |[[:human genes:z:zbtb44|ZBTB44]]|0.453| |[[:human genes:d:dohh|DOHH]]|0.448| |[[:human genes:a:atf7ip|ATF7IP]]|0.446| |[[:human genes:x:xpo6|XPO6]]|0.445| |[[:human genes:m:med23|MED23]]|0.443| |[[:human genes:a:asxl2|ASXL2]]|0.441| |[[:human genes:b:bap1|BAP1]]|0.435| |[[:human genes:r:rnmt|RNMT]]|0.432| |[[:human genes:t:tada1|TADA1]]|0.432| |[[:human genes:m:med16|MED16]]|0.426| |[[:human genes:r:rptor|RPTOR]]|0.425| |[[:human genes:s:ssb|SSB]]|0.424| |[[:human genes:s:scaf8|SCAF8]]|0.421| |[[:human genes:e:eef1e1|EEF1E1]]|0.418| |[[:human genes:c:cbx3|CBX3]]|0.417| |[[:human genes:u:uhrf1|UHRF1]]|0.416| |[[:human genes:b:brpf1|BRPF1]]|0.416| |[[:human genes:u:usp22|USP22]]|0.411| |[[:human genes:e:egln1|EGLN1]]|0.408| |[[:human genes:w:wdr82|WDR82]]|0.408| |[[:human genes:m:mllt1|MLLT1]]|0.407| |[[:human genes:d:dpagt1|DPAGT1]]|0.406| |[[:human genes:l:lsm11|LSM11]]|0.405| Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3801 * **Expression level (log2 read counts)**: 6.37 {{:chemogenomics:nalm6 dist.png?nolink |}}